Pulmonx (LUNG) Long-Term Debt Issuances (2020 - 2023)
Pulmonx (LUNG) reported Long-Term Debt Issuances of $20.0 million for Q1 2023, up 3695.07% on a QoQ basis from $527000.0 in Q4 2020.
Pulmonx (LUNG) has 2 years of Long-Term Debt Issuances data on file, last reported at $20.0 million in Q1 2023.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $20.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $20.0 million (changed N/A YoY) and the FY2023 annual result came in at $20.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances advanced to $20.0 million in Q1 2023 per LUNG's latest filing, from $527000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $20.0 million in Q1 2023 and bottomed at -$32.5 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 20.00 Mn |
| Mar 31, 2023 | 20.00 Mn |
| Dec 31, 2020 | 527,000.00 |
| Dec 31, 2020 | 527,000.00 |
| Sep 30, 2020 | 16.24 Mn |
| Sep 30, 2020 | 16.24 Mn |
| Jun 30, 2020 | -32.47 Mn |
| Jun 30, 2020 | -32.47 Mn |
| Mar 31, 2020 | 16.76 Mn |
| Mar 31, 2020 | 16.76 Mn |